First Time Loading...

Biocon Ltd
NSE:BIOCON

Watchlist Manager
Biocon Ltd Logo
Biocon Ltd
NSE:BIOCON
Watchlist
Price: 290.5 INR 0.31% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. [ Read More ]

The intrinsic value of one BIOCON stock under the Base Case scenario is 441.23 INR. Compared to the current market price of 290.5 INR, Biocon Ltd is Undervalued by 34%.

Key Points:
BIOCON Intrinsic Value
Base Case
441.23 INR
Undervaluation 34%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Biocon Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BIOCON stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Biocon Ltd

Provide an overview of the primary business activities
of Biocon Ltd.

What unique competitive advantages
does Biocon Ltd hold over its rivals?

What risks and challenges
does Biocon Ltd face in the near future?

Summarize the latest earnings call
of Biocon Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biocon Ltd.

Provide P/S
for Biocon Ltd.

Provide P/E
for Biocon Ltd.

Provide P/OCF
for Biocon Ltd.

Provide P/FCFE
for Biocon Ltd.

Provide P/B
for Biocon Ltd.

Provide EV/S
for Biocon Ltd.

Provide EV/GP
for Biocon Ltd.

Provide EV/EBITDA
for Biocon Ltd.

Provide EV/EBIT
for Biocon Ltd.

Provide EV/OCF
for Biocon Ltd.

Provide EV/FCFF
for Biocon Ltd.

Provide EV/IC
for Biocon Ltd.

Show me price targets
for Biocon Ltd made by professional analysts.

What are the Revenue projections
for Biocon Ltd?

How accurate were the past Revenue estimates
for Biocon Ltd?

What are the Net Income projections
for Biocon Ltd?

How accurate were the past Net Income estimates
for Biocon Ltd?

What are the EPS projections
for Biocon Ltd?

How accurate were the past EPS estimates
for Biocon Ltd?

What are the EBIT projections
for Biocon Ltd?

How accurate were the past EBIT estimates
for Biocon Ltd?

Compare the revenue forecasts
for Biocon Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biocon Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biocon Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biocon Ltd compared to its peers.

Compare the P/E ratios
of Biocon Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Biocon Ltd with its peers.

Analyze the financial leverage
of Biocon Ltd compared to its main competitors.

Show all profitability ratios
for Biocon Ltd.

Provide ROE
for Biocon Ltd.

Provide ROA
for Biocon Ltd.

Provide ROIC
for Biocon Ltd.

Provide ROCE
for Biocon Ltd.

Provide Gross Margin
for Biocon Ltd.

Provide Operating Margin
for Biocon Ltd.

Provide Net Margin
for Biocon Ltd.

Provide FCF Margin
for Biocon Ltd.

Show all solvency ratios
for Biocon Ltd.

Provide D/E Ratio
for Biocon Ltd.

Provide D/A Ratio
for Biocon Ltd.

Provide Interest Coverage Ratio
for Biocon Ltd.

Provide Altman Z-Score Ratio
for Biocon Ltd.

Provide Quick Ratio
for Biocon Ltd.

Provide Current Ratio
for Biocon Ltd.

Provide Cash Ratio
for Biocon Ltd.

What is the historical Revenue growth
over the last 5 years for Biocon Ltd?

What is the historical Net Income growth
over the last 5 years for Biocon Ltd?

What is the current Free Cash Flow
of Biocon Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biocon Ltd.

Financials

Balance Sheet Decomposition
Biocon Ltd

Current Assets 140.7B
Cash & Short-Term Investments 39.3B
Receivables 40.3B
Other Current Assets 61.1B
Non-Current Assets 405.1B
Long-Term Investments 14.3B
PP&E 109.2B
Intangibles 269.7B
Other Non-Current Assets 11.8B
Current Liabilities 103.7B
Accounts Payable 43.9B
Other Current Liabilities 59.7B
Non-Current Liabilities 252.3B
Long-Term Debt 153.7B
Other Non-Current Liabilities 98.6B
Efficiency

Earnings Waterfall
Biocon Ltd

Revenue
146.1B INR
Cost of Revenue
-48B INR
Gross Profit
98.2B INR
Operating Expenses
-79.6B INR
Operating Income
18.5B INR
Other Expenses
-6.5B INR
Net Income
12B INR

Free Cash Flow Analysis
Biocon Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BIOCON Profitability Score
Profitability Due Diligence

Biocon Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
53/100
Profitability
Score

Biocon Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

BIOCON Solvency Score
Solvency Due Diligence

Biocon Ltd's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
36/100
Solvency
Score

Biocon Ltd's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIOCON Price Targets Summary
Biocon Ltd

Wall Street analysts forecast BIOCON stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOCON is 287.7 INR with a low forecast of 202 INR and a high forecast of 372.75 INR.

Lowest
Price Target
202 INR
30% Downside
Average
Price Target
287.7 INR
1% Downside
Highest
Price Target
372.75 INR
28% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

BIOCON Price
Biocon Ltd

1M 1M
+13%
6M 6M
+29%
1Y 1Y
+26%
3Y 3Y
-26%
5Y 5Y
-6%
10Y 10Y
+282%
Annual Price Range
290.5
52w Low
218.7
52w High
298.55
Price Metrics
Average Annual Return 0.98%
Standard Deviation of Annual Returns 39.29%
Max Drawdown -59%
Shares Statistics
Market Capitalization 348.8B INR
Shares Outstanding 1 200 600 000
Percentage of Shares Shorted
N/A

BIOCON Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Biocon Ltd Logo
Biocon Ltd

Country

India

Industry

Biotechnology

Market Cap

348.8B INR

Dividend Yield

0.54%

Description

Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. The company is headquartered in Bangalore, Karnataka and currently employs 3,203 full-time employees. The company went IPO on 2004-04-17. The firm is also focused on developing novel therapies for diabetes, oncology and immunology. The Company’s businesses segment includes Generics, Biosimilars, Novel Biologics and Research Services. The Company’s Generic Formulations and active pharmaceutical ingredients (API)products include Rosuvastatin, Simvastatin, Atorvastatin, Fingolimod, Dapagliflozin, Pemetrexed, Simvastatin, Atorvastatin, Rosuvastatin, Dabigatran, Apixaban, Vildagliptin, Linagliptin, Empagliflozin, Repaglinide, Liraglutide, Sirolimus, Pimecrolimus, Mycophenolate Mofetil (MMF), Glatiramer Acetate, Fingolimod, Teriflunomide, Dasatinib, Lenalidomide, Pazopanib, Erdafitinib Orlistat, Mirabegron, Posaconazole, Micafungin, Anidulafungin and Brinzolamide. The Company’s portfolio includes ALZUMAb-L (Itolizumab), RemWin (Remdesivir), ARAFLU (Favipiravir) and CytoSorb.

Contact

KARNATAKA
Bangalore
20th KM, Hosur Road, Electronics City
+918028082808
http://www.biocon.com/

IPO

2004-04-17

Employees

3 203

Officers

Founder & Executive Chairperson
Ms. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc.
MD, CEO & Director
Mr. Siddharth Mittal BCom, CA, CPA
Group Chief Executive Officer
Mr. Peter James Jonathan Bains
Head of Operations
Mr. Arun Gupta
Group Chief Information Officer
Mr. Atanu Roy
Head of Investor Relations
Mr. Saurabh Paliwal
Show More
Company Secretary & Compliance Officer
Mr. Mayank Verma
Global Head of Communications & Corporate Brand
Ms. Seema Shah Ahuja BA, MBA
Head of Human Resources
Ms. Maninder Kapoor Puri
Commercial Head of Biocon Global APIs
Mr. Nehal Vora BSc, MBA
Show Less

See Also

Discover More
What is the Intrinsic Value of one BIOCON stock?

The intrinsic value of one BIOCON stock under the Base Case scenario is 441.23 INR.

Is BIOCON stock undervalued or overvalued?

Compared to the current market price of 290.5 INR, Biocon Ltd is Undervalued by 34%.